- Home
- NBTX
NBTX
Nanobiotix S.A.
as 07-26-2024 4:00pm EST
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
| Founded: | 2003 | Country: | France |
| Employees: | N/A | City: | N/A |
| Market Cap: | 205.4M | IPO Year: | 2020 |
| Target Price: | $11.00 | AVG Volume (30 days): | 3.9K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.14 - $11.00 | Next Earning Date: | 09-24-2024 |
| Revenue: | $40,230,000 | Revenue Growth: | 1267.85% |
| Revenue Growth (this year): | -6.82% | Revenue Growth (next year): | -33.91% |
Latest Nanobiotix S.A. News
NBTX Breaking Stock News: Dive into NBTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
17 days ago
Voting Rights and Shares Capital of the Company
GlobeNewswire
a month ago
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
GlobeNewswire
a month ago
Voting Rights and Shares Capital of the Company
GuruFocus.com
a month ago
A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
Energy Global
a month ago
ANDRITZ to equip new Silvan hydropower plant in Türkiye
USA TODAY
a month ago
Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
Business Wire
a month ago
Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
Business Wire
a month ago
Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
Compare NBTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NBTX Nanobiotix S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.